Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBL-514 in Dercum's Disease Lipomas
NCT06303570Phase 2Completed
- Sponsor
- Caliway Biopharmaceuticals
- Start
- Nov 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CBL-514 in Dercum's disease, sponsored by Caliway Biopharmaceuticals. Started Nov 2024; status: completed.
02
Drugs
CBL-514
03
Conditions
Dercum's disease
Beyond the preview
Go deeper on NCT06303570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06303570.